Allison Bratzel

Stock Analyst at Piper Sandler

(4.71)
# 170
Out of 5,044 analysts
43
Total ratings
70.59%
Success rate
22.04%
Average return

Stocks Rated by Allison Bratzel

IO Biotech
Oct 22, 2025
Maintains: Overweight
Price Target: $10$3
Current: $0.90
Upside: +232.96%
Scholar Rock Holding
Sep 24, 2025
Maintains: Overweight
Price Target: $52$51
Current: $29.88
Upside: +70.68%
argenx SE
Aug 26, 2025
Maintains: Overweight
Price Target: $750$820
Current: $836.39
Upside: -1.96%
Ionis Pharmaceuticals
Aug 22, 2025
Maintains: Overweight
Price Target: $62$65
Current: $73.57
Upside: -11.65%
ABIVAX Société Anonyme
Jul 29, 2025
Maintains: Overweight
Price Target: $70$112
Current: $94.25
Upside: +18.84%
Replimune Group
Jun 2, 2025
Maintains: Overweight
Price Target: $14$22
Current: $10.45
Upside: +110.53%
Tyra Biosciences
May 21, 2025
Assumes: Overweight
Price Target: $33
Current: $14.56
Upside: +126.65%
Ultragenyx Pharmaceutical
Mar 17, 2025
Maintains: Overweight
Price Target: $140$115
Current: $34.77
Upside: +230.74%
Akebia Therapeutics
Mar 14, 2025
Maintains: Overweight
Price Target: $4$6
Current: $3.09
Upside: +94.17%
enGene Holdings
Feb 18, 2025
Initiates: Overweight
Price Target: $26
Current: $7.81
Upside: +232.91%
Maintains: Neutral
Price Target: $12$22
Current: $29.81
Upside: -26.20%
Maintains: Neutral
Price Target: $15$23
Current: $29.69
Upside: -22.53%
Maintains: Overweight
Price Target: $20$22
Current: $18.41
Upside: +19.50%
Maintains: Neutral
Price Target: $4
Current: $1.70
Upside: +135.29%
Upgrades: Overweight
Price Target: $8$20
Current: $5.92
Upside: +237.84%
Assumes: Overweight
Price Target: $20
Current: $5.63
Upside: +255.24%
Maintains: Overweight
Price Target: $100
Current: $91.65
Upside: +9.11%